Description
An inhibitor of wild-type and mutant forms of LRRK2; inhibits WT LRRK2, LRRK2G2019S, and LRRK2A2016T (IC50s = 6.6, 2.2, and 47.7 nM, respectively) but not LRRK2 containing both mutations (IC50 = 3,080 nM); inhibits phosphorylation of Ser910 and Ser935 of WT LRRK2 and LRRK2G2019S in vitro; inhibits Ser935 phosphorylation in vivo in mouse brain, spleen, and kidney at 30 mg/kg
Formal name: [4-[[5-chloro-4-(methylamino)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxyphenyl]-4-morpholinyl-methanone
Synonyms:
Molecular weight: 416.9
CAS: 1700693-08-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Serine/Threonine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease